Omalizumab therapy was linked to improved inflammatory biomarkers and symptom scores after 16 weeks in patients with severe allergic asthma.
April brings a surge in childhood asthma cases, often mistaken for seasonal coughs. Rising temperatures, dust, and allergens ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results